Shandong Sanyuan Biotechnology Co., Ltd

Shandong Sanyuan Biotechnology Co., Ltd., established in 2007, is a high-tech biotechnology enterprise integrating R&D, production and sales, dedicated to researching and developing erythritol and novel multifunctional sugars via fermentation methods. Located in the Binzhou Industrial Park in Shandong Province, spanning 330 mu, the company has annual production capacity of 135,000 tons of erythritol and 20,000 tons of allulose, and has established a health sugar engineering technology R&D center in cooperation with renowned domestic universities, as well as Sanyuan Bioengineering Research (Tianjin) Co., Ltd. in the Tianjin Free Trade Zone Airport Economic Area, dedicated to building an innovation system integrating R&D, pilot testing and industrialization. The company holds 4 national invention patents and 3 utility model patents, with product quality reaching an internationally leading level, certified to ISO 9001 (quality management), ISO 14001 (environmental management) and ISO 22000 (food safety management), plus BRC food safety global standard certification, Kosher certification, Halal certification, IP non-GMO supply chain standard certification, and SMETA social responsibility audit; with self-operated import and export rights, the company's export markets are mainly in Europe and the US, spanning more than 40 countries and regions across East Asia, Southeast Asia, Australia and New Zealand, with products designated as national key new products by China's four ministries covering technology, environmental protection, commerce and inspection/quarantine, widely applied across food and beverage, health products, pharmaceutical and cosmetics industries. As health and wellness awareness grows alongside an aging population and health issues like metabolic syndrome, demand for functional health ingredients continues expanding, with the company's core product erythritol standing out among functional sugar alcohol sweeteners for its high application value; Shandong Sanyuan Biotechnology successfully listed on the Shenzhen Stock Exchange ChiNext board on February 10, 2022, under stock code 301206, upholding principles of customer focus, attentive service and fair trading while advancing the health sugar industry.